First Tracks Biotherapeutics TRAX
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts10
Average target$75.40+81.1% vs. price
- Buy 100%
Low $57.00Now $41.64Avg $75.40High $110.00
Recent rating changes
The last 20 actions on file set price targets from $50.00 to $110.00, averaging $76.68.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | J.P. Morgan | BUY | $70.00 |
| 5 Nov 2026 | CCORF | BUY | $57.00 |
| 5 Nov 2026 | Leerink Partners | BUY | $90.00 |
| 4 Nov 2026 | Wells Fargo | BUY | $70.00 |
| 4 Nov 2026 | Piper Sandler | BUY | $95.00 |
| 4 Nov 2026 | Wedbush | BUY | $70.00 |
| 4 Nov 2026 | Barclays | BUY | $65.00 |
| 3 Nov 2026 | Guggenheim | BUY | $110.00 |
| 20 Oct 2026 | Piper Sandler | BUY | $95.00 |
| 19 Oct 2026 | Leerink Partners | BUY | $90.00 |
| 16 Oct 2026 | Leerink Partners | BUY | $90.00 |
| 13 Oct 2026 | CCORF | BUY | $60.00 |
| 13 Oct 2026 | Wells Fargo | BUY | $70.00 |
| 13 Oct 2026 | Wedbush | BUY | $70.00 |
| 13 Oct 2026 | Evercore | BUY | $70.00 |
| 13 Oct 2026 | Barclays | BUY | $65.00 |
| 12 Oct 2026 | Wells Fargo | BUY | $70.00 |
| 12 Oct 2026 | Guggenheim | BUY | $100.00 |
| 12 Oct 2026 | J.P. Morgan | BUY | – |
| 9 Oct 2026 | CCORF | BUY | $50.00 |
No comments yet — be the first to weigh in on TRAX.
Sign in to join the discussion.